BACKGROUND: Prevention of bacterial sexually transmitted infections (STIs) among men who have sex with men (MSM) requires timely disease detection, but this is complicated by asymptomatic infection. We estimated screening/testing rates by symptomatic status to evaluate adherence to Centers for Disease Control and Prevention STI screening guidelines. METHODS: In a cross-sectional study of 2572 US MSM aged 15 to 65 years in 2017 to 2018, we measured the reported number of asymptomatic STI screens in the past 2 years versus tests prompted by disease symptoms. Using negative binominal regression within a hierarchical Bayesian framework, we estimated yearly rates of asymptomatic screening and symptomatic testing by geographic, demographic, and behavioral factors. RESULTS: Human immunodeficiency virus (HIV) status was most strongly associated with all testing/screening frequency (incidence rate ratio [IRR], 1.72; 95% credible interval [Crl], 1.49, 1.97). The HIV-uninfected MSM had 0.14 (95% credible interval [CrI], 0.12-0.17) symptomatic tests and 0.88 (95% CrI, 0.77-1.01) asymptomatic screens per year. The HIV-infected MSM had 0.25 (95% CrI, 0.18-0.35) symptomatic tests and 1.53 (95% CrI, 1.24-1.88) asymptomatic screens per year. Rates of asymptomatic screening were higher among black compared with white MSM (IRR, 1.41; 95% CrI, 1.15-1.73), but weakly associated with number of past-year sexual partners (IRR, 1.01; 95% CrI, 1.00-1.01). Overall, 85% to 90% of diagnostic events were asymptomatic screens. CONCLUSIONS: Self-reported rates of STI screening were close to Centers for Disease Control and Prevention's recommended overall annual screening frequency, but with gaps defined by demographics and behavioral risk. Targeted screening efforts may be indicated specifically for younger MSM and those with multiple partners.
BACKGROUND: Prevention of bacterial sexually transmitted infections (STIs) among men who have sex with men (MSM) requires timely disease detection, but this is complicated by asymptomatic infection. We estimated screening/testing rates by symptomatic status to evaluate adherence to Centers for Disease Control and Prevention STI screening guidelines. METHODS: In a cross-sectional study of 2572 US MSM aged 15 to 65 years in 2017 to 2018, we measured the reported number of asymptomatic STI screens in the past 2 years versus tests prompted by disease symptoms. Using negative binominal regression within a hierarchical Bayesian framework, we estimated yearly rates of asymptomatic screening and symptomatic testing by geographic, demographic, and behavioral factors. RESULTS:Human immunodeficiency virus (HIV) status was most strongly associated with all testing/screening frequency (incidence rate ratio [IRR], 1.72; 95% credible interval [Crl], 1.49, 1.97). The HIV-uninfected MSM had 0.14 (95% credible interval [CrI], 0.12-0.17) symptomatic tests and 0.88 (95% CrI, 0.77-1.01) asymptomatic screens per year. The HIV-infected MSM had 0.25 (95% CrI, 0.18-0.35) symptomatic tests and 1.53 (95% CrI, 1.24-1.88) asymptomatic screens per year. Rates of asymptomatic screening were higher among black compared with white MSM (IRR, 1.41; 95% CrI, 1.15-1.73), but weakly associated with number of past-year sexual partners (IRR, 1.01; 95% CrI, 1.00-1.01). Overall, 85% to 90% of diagnostic events were asymptomatic screens. CONCLUSIONS: Self-reported rates of STI screening were close to Centers for Disease Control and Prevention's recommended overall annual screening frequency, but with gaps defined by demographics and behavioral risk. Targeted screening efforts may be indicated specifically for younger MSM and those with multiple partners.
Authors: R Guy; J L Goller; T Spelman; C El-Hayek; J Gold; M Lim; D Leslie; B K Tee; N Roth; J Anderson; C K Fairley; J Kaldor; M Hellard Journal: Sex Transm Infect Date: 2010-05-10 Impact factor: 3.519
Authors: Jeffrey D Klausner; Charlotte K Kent; William Wong; Jacque McCright; Mitchell H Katz Journal: Sex Transm Dis Date: 2005-10 Impact factor: 2.830
Authors: Bonnie B Dean; Mia Scott; Rachel Hart; Linda Battalora; Richard M Novak; Marcus D Durham; John T Brooks; Kate Buchacz Journal: Sex Transm Dis Date: 2017-11 Impact factor: 2.830
Authors: Charlotte K Kent; Janice K Chaw; William Wong; Sally Liska; Steven Gibson; Gregory Hubbard; Jeffrey D Klausner Journal: Clin Infect Dis Date: 2005-05-26 Impact factor: 9.079
Authors: Sara Nelson Glick; Martina Morris; Betsy Foxman; Sevgi O Aral; Lisa E Manhart; King K Holmes; Matthew R Golden Journal: J Acquir Immune Defic Syndr Date: 2012-05-01 Impact factor: 3.731
Authors: Gunter Rieg; Roger J Lewis; Loren G Miller; Mallory D Witt; Mario Guerrero; Eric S Daar Journal: AIDS Patient Care STDS Date: 2008-12 Impact factor: 5.078
Authors: Alex de Voux; Sarah Kidd; Jeremy A Grey; Eli S Rosenberg; Thomas L Gift; Hillard Weinstock; Kyle T Bernstein Journal: MMWR Morb Mortal Wkly Rep Date: 2017-04-07 Impact factor: 17.586
Authors: Kevin M Weiss; Pragati Prasad; Ramya Ramaraju; Maria Zlotorzynska; Samuel M Jenness Journal: J Acquir Immune Defic Syndr Date: 2020-05-01 Impact factor: 3.771
Authors: Ben B Hui; Thilini N Padeniya; Nic Rebuli; Richard T Gray; James G Wood; Basil Donovan; Qibin Duan; Rebecca Guy; Jane S Hocking; Monica M Lahra; David A Lewis; David M Whiley; David G Regan; Kate L Seib Journal: J Infect Dis Date: 2022-03-15 Impact factor: 5.226
Authors: Kevin M Weiss; Jeb S Jones; Emeli J Anderson; Thomas Gift; Harrell Chesson; Kyle Bernstein; Kimberly Workowski; Ashleigh Tuite; Eli S Rosenberg; Patrick S Sullivan; Samuel M Jenness Journal: Open Forum Infect Dis Date: 2019-10-25 Impact factor: 3.835